Patent applications for HIV prevention drug opposed in India

U.S.-based pharmaceutical company Gilead Sciences filed patent claims on the HIV drug Lenacapavir this week

from India Latest News: Top National Headlines Today & Breaking News | The Hindu https://ift.tt/SrxlyQi
via IFTTT